About the Product

Description


Trimbute 300 Tablet containing Trimebutine is used for the management of irritable bowel syndrome (IBS), abdominal cramps, and digestive motility disorders. It helps regulate intestinal movement and provides effective symptomatic relief.

Trimebutine works as a gastrointestinal modulator that helps normalize gut motility, reducing spasms, bloating, and abdominal discomfort.

The tablet is widely prescribed in gastroenterology practice for IBS and functional bowel disorders, leading to consistent prescription demand.

With increasing prevalence of lifestyle-related digestive issues and growing awareness of IBS management, this product offers strong business potential for retailers and distributors. Its targeted action on gut motility, broad clinical relevance, and steady market demand make it a reliable product for growth in the gastroenterology segment.

Some patients may experience nausea, dizziness, dry mouth, constipation, or mild abdominal discomfort. Rarely, allergic skin reactions may occur.

Trimbute 300 Tablet is indicated for irritable bowel syndrome (IBS), abdominal cramps, bloating, functional dyspepsia, and irregular bowel habits. It helps relieve abdominal pain, regulate bowel movement, reduce spasms, and improve digestive comfort.

This medicine should be used under medical supervision. Do not exceed the recommended dose. Use cautiously in patients with severe liver or kidney impairment.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Trimbute 300 Tablet in the PCD pharma franchise market?

Trimbute 300 Tablet, containing Trimebutine 300mg, has strong demand in the gastroenterology segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on digestive health and GI care portfolios.

Why should medical distributors include Trimbute 300 Tablet in their product range?

Medical distributors and agencies can benefit from the consistent demand for gastrointestinal motility regulators used in irritable bowel syndrome (IBS), abdominal pain, bloating, intestinal spasms, and digestive discomfort. Trimbute 300 Tablet helps strengthen a comprehensive gastro care product portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for Trimbute 300 Tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Trimbute 300 Tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for Trimbute 300 Tablet distribution?

Wholesalers and medical agencies benefit from steady gastro prescription demand, repeat patient usage, reliable supply chain support, and good margins when partnering for Trimbute 300 Tablet distribution.

How can I become a distributor or franchise partner for Trimbute 300 Tablet?

Medical distributors, stockists, and wholesalers interested in Trimbute 300 Tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.